Description of the regulatory framework of the share repurchase program proposed to the Ordinary Shareholders’ Meeting of 4 June 2014

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2022